Skip to main content
Journal cover image

Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala.

Publication ,  Journal Article
Chung, L; Moore, SD
Published in: Neuropeptides
December 2007

The neuropeptide cholecystokinin (CCK) is anxiogenic in studies of human and animal behavior. As the amygdala formation has been implicated in generation of emotional states such as anxiety, we tested the effect of CCK on spontaneous synaptic events in the basolateral amygdala (BLA) using whole cell patch recordings in rat brain slice preparation. We found that CCK increased the frequency of spontaneous inhibitory postsynaptic potentials (sIPSPs) and currents (sIPSCs). This effect was blocked by the fast sodium channel blocker tetrodotoxin (TTX), indicating that the CCK effect is likely mediated by direct excitation of GABAergic interneurons. The CCK(B) receptor subtype antagonist, CR2945, blocked the CCK effect, while CCK4, a specific CCK(B) agonist, increased sIPSC frequency. We hypothesize that these actions may underlie the anxiogenic effects of CCK observed in behavioral studies.

Duke Scholars

Published In

Neuropeptides

DOI

ISSN

0143-4179

Publication Date

December 2007

Volume

41

Issue

6

Start / End Page

453 / 463

Location

Netherlands

Related Subject Headings

  • gamma-Aminobutyric Acid
  • Synaptic Transmission
  • Rats
  • Patch-Clamp Techniques
  • Neurology & Neurosurgery
  • Interneurons
  • Inhibitory Postsynaptic Potentials
  • Cholecystokinin
  • Brain
  • Anxiety
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chung, L., & Moore, S. D. (2007). Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala. Neuropeptides, 41(6), 453–463. https://doi.org/10.1016/j.npep.2007.08.001
Chung, L., and S. D. Moore. “Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala.Neuropeptides 41, no. 6 (December 2007): 453–63. https://doi.org/10.1016/j.npep.2007.08.001.
Chung L, Moore SD. Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala. Neuropeptides. 2007 Dec;41(6):453–63.
Chung, L., and S. D. Moore. “Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala.Neuropeptides, vol. 41, no. 6, Dec. 2007, pp. 453–63. Pubmed, doi:10.1016/j.npep.2007.08.001.
Chung L, Moore SD. Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala. Neuropeptides. 2007 Dec;41(6):453–463.
Journal cover image

Published In

Neuropeptides

DOI

ISSN

0143-4179

Publication Date

December 2007

Volume

41

Issue

6

Start / End Page

453 / 463

Location

Netherlands

Related Subject Headings

  • gamma-Aminobutyric Acid
  • Synaptic Transmission
  • Rats
  • Patch-Clamp Techniques
  • Neurology & Neurosurgery
  • Interneurons
  • Inhibitory Postsynaptic Potentials
  • Cholecystokinin
  • Brain
  • Anxiety